Abstract

In the classic treatment of Trichomonas vaginalis infection, although metronidazole has been used since the 1960s, there has been an increase in MTZ-resistant T. vaginalis strains and failure in the treatment of trichomoniasis causes serious concerns. Therefore, the present study aimed to investigate the in vitro antitrichomonal activities of extracts (ethanol and total alkaloid) and pure compounds (chrysosplenetin, dictamnine, gamma-Fagarine, skimmianine) of H. myrtifolium against T. vaginalis. H. myrtifolium was collected from the town of Honaz in Denizli, located in the Aegean region of Turkey, and preparation of extracts and isolation and structure elucidation of pure compounds were performed. Later, different concentrations of extracts and pure compounds were incubated with T. vaginalis trophozoites isolated from Turkey, which are known to be sensitive to metronidazole. It was found that ethanol extract caused a more effective lysis on T. vaginalis trophozoites compared with total alkaloid extract (P < 0.05). No compounds except for furoquinoline alkaloid skimmianine prepared above 37.5 µg/mL were found to have any inhibitory effect on T. vaginalis trophozoites. The ethanol extract of H. myrtifolium and skimmianine can be considered as potential candidates for antitrichomonal drug development.

Highlights

  • In the classic treatment of Trichomonas vaginalis infection, metronidazole has been used since the 1960s, there has been an increase in MTZ-resistant T. vaginalis strains and failure in the treatment of trichomoniasis causes serious concerns

  • No immotile T. vaginalis trophozoites or active lysis was observed when ethanol and alkaloid extracts were applied at a concentration of 50 μg/mL and 100 μg/mL at 24, 48, and 72 hours of incubation

  • Gökmen et al – Antitrichomonal activity of H. myrtifolium prepared in a final concentration of 0.5% (v/v) showed no statistically important anti-T. vaginalis activity when compared with the negative control groups (P > 0.05)

Read more

Summary

Introduction

In the classic treatment of Trichomonas vaginalis infection, metronidazole has been used since the 1960s, there has been an increase in MTZ-resistant T. vaginalis strains and failure in the treatment of trichomoniasis causes serious concerns. The present study aimed to investigate the in vitro anti-Trichomonas vaginalis activities of extracts and pure compounds (chrysosplenetin, dictamnine, gamma-Fagarine, skimmianine) of H. myrtifolium against T. vaginalis in comparison with MTZ, which is the reference drug for the treatment of trichomoniasis. Results No immotile T. vaginalis trophozoites or active lysis was observed when ethanol and alkaloid extracts were applied at a concentration of 50 μg/mL and 100 μg/mL at 24, 48, and 72 hours of incubation.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call